medigraphic.com
SPANISH

Dermatología Cosmética, Médica y Quirúrgica

Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Instructions for authors        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2003, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2003; 1 (1)

Cyclosporine in dermatology: own experience illustrated by selected case reports

Salomon J, Szepietowski JC, Baran E
Full text How to cite this article

Language: Spanish
References: 15
Page: 31-35
PDF size: 104.66 Kb.


Key words:

Cyclosporine, immunosuppressive therapy, psoriasis, atopic dermatitis.

ABSTRACT

Cyclosporin is a potent immunosuppressive agent introduced to control organ transplantation in 1978. The mechanism of its action is mainly based on inhibition of T helper 1 cells. Nowadays it is widely used in different branches of medicine, including dermatology. In the present paper the review of cyclosporin use in variety of dermatological condition is given. Moreover own experience with cyclosporin illustrated by selected case reports is presented.


REFERENCES

  1. Kauvar AB, Stiller MJ. Cyclosporine in dermatology: pharmacology and clinical use. Int J Dermatol 1994; 33: 86-96

  2. Calne RY, White DJG, Thiru S et al. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 1978; ii: 1323-1327

  3. Biren CA, Barr RJ. Dermatologic applications of cyclosporine. Arch Dermatol 1986; 122: 1028-1032

  4. Borel JF, Di Padova F, Mason J et al. Cyclosporine. Pharmacol Rev 1989; 41: 239-439

  5. Hess AD, Esa AH, Colombani PM. Mechanism of action of cyclosporine: effects on cells of the immune system and on subcellular events in T cell activation. Trans plant Proc 1988; 20: 29-40

  6. Wasik F, Wasik A. Indications to cyclosporine therapy in dermatology. Medipress 1999; suppl. 4: 4-6

  7. Finzi AF, Ippolito F, Paonesi E et al. Cyclosporine therapy in psoriasis: recommendations for treatment. Dermatology 1993; 187 (suppl 1): 38-40

  8. Logan RA, Camp RDR. Severe atopic eczema: response to oral cyclosporine A. J R Soc Med. 1988; 81: 417-418

  9. Taylor RS, Cooper KD, Headington JT et al. Cyclosporin therapy for severe atopic dermatitis. J Am Acad Dermatol 1989; 21: 580-583

  10. Curley RK, MacFarlane AW, Vickers CFH. Pyoderma gangrenosum treated with cyclosporine A. Br J Dermatol 1985; 113: 601-604

  11. Matis WL, Ellis CN, Griffiths CE, Lazarus GS. Treatment of pyoderma gangrenosum with cyclosporine. Arch Dermatol 1992; 128: 1519-1529

  12. Ho VC, Gupta AK, Ellis CN et al. Treatment of severe lichen planus with cyclosporine. J Am Acad Dermatol 1990; 22: 64-68

  13. Barthelemy H, Frappaz A, Cambazard F et al. Treatment of nine cases of pemphigus vulgaris with cyclosporine. J Am Acad Dermatol 1988; 18: 1262-1266

  14. Szepietowski J, Wasik F, Szybejko-Machaj G, Maj J. Toxic epidermal necrolysis successfully treated with cyclosporin. Report of three cases. J Eur Acad Dermatol Venereol 1997; 9: 169-172

  15. Wasik F, Kolodziej T. Indications to cyclosporine therapy in immunologic skin diseases. Medipress 1999; suppl 4: 15-17




2020     |     www.medigraphic.com

Mi perfil

C?MO CITAR (Vancouver)

Dermatología Cosmética, Médica y Quirúrgica. 2003;1